Graphene family nanomaterials for application in cancer combination photothermal therapy
- 24 June 2019
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 7 (9) , 3534-3551
Abstract
Graphene family nanomaterials mediated photothermal therapy can improve the efficacy of chemo-, photodynamic-, gene-, radio-, and immuno-therapies.Keywords
Funding Information
- European Regional Development Fund (POCI-01-0145-FEDER-007491, CENTRO-01-0145-FEDER-028989)
- Fundação para a Ciência e a Tecnologia (UID/Multi/00709/2013)
- Universidade da Beira Interior
This publication has 97 references indexed in Scilit:
- Graphene oxide mediated delivery of methylene blue for combined photodynamic and photothermal therapyBiomaterials, 2013
- Photothermally Triggered Cytosolic Drug Delivery via Endosome Disruption Using a Functionalized Reduced Graphene OxideACS Nano, 2013
- Polyethylene Glycol and Polyethylenimine Dual‐Functionalized Nano‐Graphene Oxide for Photothermally Enhanced Gene DeliverySmall, 2013
- PEGylated Graphene Oxide-Mediated Protein Delivery for Cell Function RegulationACS Applied Materials & Interfaces, 2012
- Multimodal Imaging Guided Photothermal Therapy using Functionalized Graphene Nanosheets Anchored with Magnetic NanoparticlesAdvanced Materials, 2012
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Functional Graphene Oxide as a Nanocarrier for Controlled Loading and Targeted Delivery of Mixed Anticancer DrugsSmall, 2010
- Nano-graphene oxide for cellular imaging and drug deliveryNano Research, 2008
- PEGylated Nanographene Oxide for Delivery of Water-Insoluble Cancer DrugsJournal of the American Chemical Society, 2008
- Preparation of Graphitic OxideJournal of the American Chemical Society, 1958